| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.081 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |